Estimates of potential TAVI candidates highlight a significant upcoming burden on healthcare resources, especially if indications expand to low-risk patients.
Currently, approximately 180 000 patients can be considered potential TAVI candidates in the European Union and in Northern-America annually. This number might increase up to 270 000 if indications for TAVI expand to low-risk patients. These findings have major implications for health care resource planning in the 29 individual countries.
Durko et al. (2018) studied this question.